Clincosm LogoSign in Get a demo

Generalized Myasthenia Gravis

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Generalized Myasthenia Gravis Trial (rozanolixizumab)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • (no location specified)
Nov 28, 2023

Generalized Myasthenia Gravis Trial in Columbia (Whole-body Electrical Muscle Stimulation Exercise)

Active, not recruiting
  • Generalized Myasthenia Gravis
  • Whole-body Electrical Muscle Stimulation Exercise
  • Columbia, Missouri
    NextGen Precision Health Building, Clinical Translational Scienc
Sep 26, 2023

Generalized Myasthenia Gravis Trial (Zilucoplan)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • (no location specified)
Sep 20, 2023

Generalized Myasthenia Gravis Trial in Worldwide (Pozelimab + Cemdisiran, Cemdisiran, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • Pozelimab + Cemdisiran
  • +3 more
  • Phoenix, Arizona
  • +46 more
Jan 31, 2023

Generalized Myasthenia Gravis Trial in Carlsbad (Batoclimab 680 mg SC weekly, Batoclimab 340 mg SC weekly, Matching Placebo SC)

Recruiting
  • Generalized Myasthenia Gravis
  • Batoclimab 680 mg SC weekly
  • +3 more
  • Carlsbad, California
  • +14 more
Jan 31, 2023

Generalized Myasthenia Gravis Trial (Efgartigimod IV)

Recruiting
  • Generalized Myasthenia Gravis
  • Efgartigimod IV
  • Leiden, Netherlands
  • +2 more
Jan 16, 2023

Generalized Myasthenia Gravis Trial (Rozanolixizumab)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • (no location specified)
Jan 4, 2023

Generalized Myasthenia Gravis Trial in Spain, United States (ALXN1720, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • ALXN1720
  • Placebo
  • Gainesville, Georgia
  • +7 more
Dec 20, 2022

Generalized Myasthenia Gravis, Myasthenia Gravis Trial in Worldwide (ALXN2050, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • Myasthenia Gravis
  • Phoenix, Arizona
  • +45 more
Dec 15, 2022

Generalized Myasthenia Gravis, gMG Trial (Ravulizumab)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • gMG
  • (no location specified)
Dec 1, 2022

Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))

Not yet recruiting
  • Generalized Myasthenia Gravis
  • zilucoplan (RA101495)
  • (no location specified)
Aug 22, 2022

Generalized Myasthenia Gravis Trial in Worldwide (Satralizumab, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • Scottsdale, Arizona
  • +94 more
Aug 16, 2022

Generalized Myasthenia Gravis Trial in Canada, United States (zilucoplan (RA101495), Placebo)

Completed
Has Results
  • Generalized Myasthenia Gravis
  • zilucoplan (RA101495)
  • Placebo
  • Mobile, Alabama
  • +29 more
Jul 26, 2022

Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab)

Active, not recruiting
  • Generalized Myasthenia Gravis
  • Orange, California
  • +68 more
Jul 18, 2022

Generalized Myasthenia Gravis Trial in Worldwide (Efgartigimod IV)

Recruiting
  • Generalized Myasthenia Gravis
  • Efgartigimod IV
  • Wien, Austria
  • +12 more
Jul 19, 2022

Generalized Myasthenia Gravis Trial in Worldwide (ARGX-113)

Completed
  • Generalized Myasthenia Gravis
  • ARGX-113
  • Carlsbad, California
  • +51 more
Jul 8, 2022

Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC)

Active, not recruiting
  • Generalized Myasthenia Gravis
  • efgartigimod PH20 SC
  • Carlsbad, California
  • +46 more
Jul 5, 2022

Generalized Myasthenia Gravis Trial in Worldwide (M281)

Terminated
Has Results
  • Generalized Myasthenia Gravis
  • Phoenix, Arizona
  • +53 more
Jan 25, 2022

Generalized Myasthenia Gravis Trial in Phoenix (ALXN1830, Placebo)

Withdrawn
  • Generalized Myasthenia Gravis
  • Phoenix, Arizona
    Clinical Study Site
Feb 2, 2022

Generalized Myasthenia Gravis Trial in Worldwide (ARGX-113, Placebo)

Completed
Has Results
  • Generalized Myasthenia Gravis
  • ARGX-113
  • Placebo
  • Phoenix, Arizona
  • +65 more
Jan 14, 2022

Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC, efgartigimod IV)

Completed
  • Generalized Myasthenia Gravis
  • efgartigimod PH20 SC
  • efgartigimod IV
  • Carlsbad, California
  • +46 more
Jan 31, 2022

Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab, Placebo)

Completed
  • Generalized Myasthenia Gravis
  • Phoenix, Arizona
  • +91 more
Nov 25, 2021

Generalized Myasthenia Gravis Trial in Worldwide (M281, Placebo)

Completed
Has Results
  • Generalized Myasthenia Gravis
  • Phoenix, Arizona
  • +60 more
Sep 28, 2021

Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab)

Completed
  • Generalized Myasthenia Gravis
  • Phoenix, Arizona
  • +36 more
Sep 27, 2021

Generalized Myasthenia Gravis Trial in United States

Recruiting
  • Generalized Myasthenia Gravis
    • Phoenix, Arizona
    • +9 more
    Dec 16, 2020